loading

Collegium Pharmaceutical Inc Azioni (COLL) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-06-30 2025-03-31 2024-09-30 2024-06-30 2024-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
5.76%
188.00
177.76 159.30 145.28 144.92
Cost Of Revenue
1.02%
79.62
80.43 62.51 54.47 53.47
Gross Profit
11.36%
108.38
97.32 96.79 90.81 91.46
Operating Expenses
3.12%
73.28
75.64 61.95 43.34 41.98
Benefits Costs and Expenses
2.10%
170.97
174.63 143.72 116.18 108.30
Costs And Expenses
2.10%
170.97
174.63 143.72 116.18 108.30
Operating Income/Loss
61.87%
35.10
21.69 34.84 47.47 49.47
Income/Loss From Continuing Operations Before Tax
445.32%
17.02
3.122 15.58 29.10 36.62
Income Tax Expense/Benefit, Deferred
440.63%
-2.914
-0.539 -8.733 -3.513 -4.412
Income Tax Expense/Benefit
615.18%
5.042
0.705 6.245 9.491 8.909
Income/Loss From Continuing Operations After Tax
395.78%
11.98
2.417 9.335 19.61 27.71
Net Income/Loss
395.78%
11.98
2.417 9.335 19.61 27.71
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.05%
31.81
31.79 32.26 32.43 32.33
Diluted Average Shares
18.99%
39.08
32.84 40.16 40.38 41.44
Basic Earnings Per Share
375.00%
0.38
0.08 0.29 0.60 0.86
Diluted Earnings Per Share
385.71%
0.34
0.07 0.27 0.52 0.71
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$28.98
price down icon 0.07%
$17.90
price up icon 0.62%
drug_manufacturers_specialty_generic RDY
$14.21
price down icon 1.73%
$10.41
price down icon 1.33%
$136.84
price up icon 2.13%
$309.22
price up icon 1.26%
Capitalizzazione:     |  Volume (24 ore):